AOSSM 2022 Annual Meeting Recordings - no CME-Leukocyte-Poor Platelet Rich Plasma versus Leukocyte-Poor Platelet Rich Plasma Plus Hyaluronic Acid for the Treatment of Symptomatic Knee Osteoarthritis: A Prospective, Randomized Control Trial with 2 Year Follow Up

Leukocyte-Poor Platelet Rich Plasma versus Leukocyte-Poor Platelet Rich Plasma Plus Hyaluronic Acid for the Treatment of Symptomatic Knee Osteoarthritis: A Prospective, Randomized Control Trial with 2 Year Follow Up

Back to course

Video Transcription

Video Summary

This video discusses the results of a randomized controlled trial study on the use of hyaluronic acid in combination with platelet-rich plasma (PRP) for treating osteoarthritis. The study was not industry-sponsored and was funded by a grant from the state of Florida. The researchers examined the effectiveness of PRP alone versus PRP with hyaluronic acid over a 24-month period. The study found that both treatments were effective and showed significant improvements in outcome measures such as Womack and KOOS scores at one month, which sustained up to 24 months. However, the addition of hyaluronic acid did not provide superior results compared to PRP alone. The study's findings may be further clarified through meta-analysis with other research sites. The study's duration of 24 months distinguishes it from previous 12-month studies.

Asset Caption

Adam Anz, MD

Keywords

randomized controlled trial

hyaluronic acid

platelet-rich plasma

osteoarthritis

effectiveness